We help you to see what you've always wanted
Directorio Médico

Nuestro equipo de profesionales cuenta con la mayor experiencia en la región. Realice su búsqueda seleccionando la especialidad o ingresando el nombre del especialista.

Perfil del especialista

Teléfono: 511 02 67
Consultorio: 211

Dra.
Angela María Dolmetsch Cuevas
ESPECIALIDAD
  • Oftalmología
  • Cirugía Plástica Ocular
  • Vías Lagrimales y Orbita
  • Patologia Ocular

 

ENTRENAMIENTO
  • Médico Cirujano (1988 – Universidad del Valle)
  • Oftalmología (1994 – Universidad del Valle)
  • Oculoplástica y Patología Ocular (1996 – McGill University)

 

PREMIOS
  • Beca Gillingham en Oftalmología (2004 – Asociacion Pan-Americana de Oftalmologia)
  • Premio Internacional de Oftalmología en Educación (2007 – Academia Americana de Oftalmologia)
  • Premio al mejor Video Cientifico (2008 – Sociedad Colombiana de Oftalmologia)

 

 

CONFERENCIAS
  • Compostela (España)
    Dacriocistorrinostomía Endoscópica Transnasal. – Junio 2010
  • Compostela (España)
    Blefaroplastia Superior y Correccion de Ptosis Palpebral por Conjuntivomullerctomia – Junio 2010
  • San Francisco (USA)
    Dacriocistorrinostomía Endoscópica Transnasal – Octubre 2.009

 

INVESTIGACIONES
  • Nonlaser Endoscopic Endonasal Dacryocystorhinostomy with adjunctive Mitomycin C in Nasolacrimal Duct Obstruction in Adults
    Resumen: PURPOSE: To determine the outcome and safety of nonlaser endonasal dacryocystorhinostomy (NLEN-DCR) with the use of adjunctive mitomycin C (MMC) in congenital, traumatic, and primary acquired nasolacrimal duct obstruction in adults. DESIGN: Retrospective, nonrandomized, noncomparative, case series. PARTICIPANTS: One hundred ninety-three consecutive adult patients underwent NLEN-DCR with the use of adjunctive MMC. Thirty-one patients had a simultaneous bilateral procedure performed. METHODS: All patients underwent a standardized procedure, with an endonasal approach to the lacrimal sac, surgical removal of nasal mucosa, lacrimal bone, and a fragment of the frontal process of the maxilla. The medial wall of the lacrimal sac was removed completely, and a neurosurgical cottonoid soaked in MMC at 0.5 mg/ml was placed at the osteotomy site for 10 minutes. All patients underwent bicanalicular silicone intubation. MAIN OUTCOME MEASURES: Resolution of epiphora, absence of discharge, and patency of the ostium confirmed by irrigation at 6 months. RESULTS: The NLEN-DCR procedure with adjunctive MMC was successful in 212 (95%) cases. The mean follow-up was 18.2 months. Intubation of more than 3 months was associated with a higher rate of obstruction (P
    Enlace: http://www.ncbi.nlm.nih.gov/pubmed/20079535
  • Nonlaser endoscopic endonasal dacryocystorhinostomy with adjunctive mitomycin C in children
    Resumen: Abstract PURPOSE: To determine the outcome and safety of pediatric endonasal dacryocystorhinostomy with the use of adjunctive mitomycin C. METHODS: A prospective, nonrandomized and noncomparative interventional case series study was performed in 71 consecutive procedures. Sixty patients 16 years of age and younger underwent nonlaser endonasal dacryocystorhinostomy with the use of adjunctive mitomycin C. Eleven patients had a simultaneous bilateral procedure performed. All patients underwent a standardized procedure, with an endonasal approach to the lacrimal sac and surgical removal of nasal mucosa, lacrimal bone, and a fragment of the frontal process of the maxilla. The medial wall of the lacrimal sac was completely removed and a neurosurgical cottonoid soaked in mitomycin C at 0.5 mg/ml placed at the osteotomy site for 5 minutes. All patients underwent bicanalicular or monocanalicular silicone intubation. RESULTS: The main outcome measures were the resolution of epiphora, lacrimal discharge, and patency of the ostium confirmed either by endoscopic visualization and/or irrigation at 6 months or a normal dye disappearance test. Thirteen patients’ (18%) final evaluation was via telephone survey. The mean follow-up was 12.3 months. Nonlaser endonasal dacryocystorhinostomy with adjunctive mitomycin C was successful in 67 cases (94.4%). African descent was strongly associated with a higher rate of obstruction (p < 0.001). Infection at the time of surgery (p = 0.051) and less than 3 months intubation (p = 0.059) were also borderline significant. Previous trauma, gender, age, and side operated had no influence on the final outcome. No significant complications were encountered. CONCLUSIONS: Nonlaser endonasal dacryocystorhinostomy with mitomycin C is a safe and successful procedure for the treatment of congenital nasolacrimal duct obstruction in children. It has the advantage of leaving no scar and of preserving the medial canthal structures. It can be successfully performed as a simultaneous bilateral procedure.
    Enlace: http://www.ncbi.nlm.nih.gov/pubmed/18806661
  • Orbital granulocytic sarcoma
    Resumen: Abstract AIM: Orbital granulocytic sarcoma is a localised tumour composed of cells of myeloid origin. Histological diagnosis can be difficult in patients with poorly differentiated orbital tumours and no evidence of systemic leukaemia. The naphthol AS-D chloracetate esterase (Leder stain) and immunohistochemical stains for lysozyme and MAC387 were used to determine the staining characteristics of these tumours. A case series of seven patients with orbital granulocytic sarcoma is presented. METHODS: Seven patients with orbital granulocytic sarcoma were studied. Haematoxylin and eosin, Leder, and lysozyme stained sections were available in seven cases. Unstained formalin fixed paraffin embedded sections of seven cases were available for immunohistochemical evaluation using the avidin-biotin-complex technique for MAC387. RESULTS: The mean age of presentation of the orbital tumour was 8.8 years. Four patients presented with an orbital tumour before any systemic manifestations of leukaemia. In two cases the diagnosis of the orbital tumour and systemic leukaemia was made simultaneously. There was one case of established systemic myeloid leukaemia in remission with the subsequent development of orbital granulocytic sarcoma. Six of seven cases (86%) were positive for the Leder stain. Five of seven cases (71%) showed positive immunoreactivity with lysozyme. The immunohistochemical stain for MAC387 was positive in all seven cases (100%) including one case that was negative for both lysozyme and Leder stains. CONCLUSIONS: Orbital granulocytic sarcoma is a tumour that affects children and can present with rapidly progressive proptosis. This tumour may develop before, during, or after the occurrence of systemic leukaemia. The combination of Leder and lysozyme stains is useful in the diagnosis of orbital granulocytic sarcoma. MAC387 may be a more reliable marker for orbital granulocytic sarcoma.
    Enlace: http://www.ncbi.nlm.nih.gov/pubmed/9497470

 

CONGRESOS Y ACTUALIZACIONES
  • II Congreso iberoamericano de oculoplastica (Junio 2010)
    Santiago de Compostela – España
  • Academia Americana de Oftalmologia (Octubre 2009)
    San Francisco – USA
  • Reunion anual Asociacion Americana de Cirugia Plastica Ocular. (ASOPRS) (Octubre 2009)
    San Francisco – USA